$ENZN Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ENZON PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in ENZON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ENZON PHARMACEUTICALS, INC. for free.

Page:   1 2 3 4 5 ... 5 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 29 2016ENZNENZON PHARMACEUTIC ...ICAHN CARL C10% OwnerOption ExerciseH1.09110
Nov 29 2016ENZNENZON PHARMACEUTIC ...ICAHN CARL C10% OwnerBuyP0.41694,023281,0796,598,8865.9 M to 6.6 M (+11.75 %)
Sep 19 2013ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorSellS1.6921,11935,62642,18963.3 K to 42.2 K (-33.36 %)
Sep 19 2013ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorSellS1.7434,80760,45663,30898.1 K to 63.3 K (-35.48 %)
Jan 25 2013ENZNENZON PHARMACEUTIC ...Rackear Andrew D.VP and General Coun ...GrantA0.004,686078,01973.3 K to 78 K (+6.39 %)
Jan 25 2013ENZNENZON PHARMACEUTIC ...Buchbinder AbyVP, Clinical Develo ...GrantA0.003,748079,24675.5 K to 79.2 K (+4.96 %)
Jan 25 2013ENZNENZON PHARMACEUTIC ...Conover CharlesSVP, R&D Program Ma ...GrantA0.002,343074,79372.5 K to 74.8 K (+3.23 %)
Jan 04 2013ENZNENZON PHARMACEUTIC ...Young Richard ADirectorOption ExerciseA4.5420,12991,38620,129
Jan 04 2013ENZNENZON PHARMACEUTIC ...Deuel ThomasDirectorOption ExerciseA4.5420,12991,38620,129
Jan 04 2013ENZNENZON PHARMACEUTIC ...SALISBURY ROBERT CDirectorOption ExerciseA4.5420,12991,38620,129
Jan 04 2013ENZNENZON PHARMACEUTIC ...Mulligan RichardDirectorOption ExerciseA4.5435,226159,92635,226
Jan 04 2013ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorOption ExerciseA4.5420,12991,38620,129
Jan 04 2013ENZNENZON PHARMACEUTIC ...DENNER ALEXANDER JDirectorOption ExerciseA4.5440,258182,77140,258
Nov 08 2012ENZNENZON PHARMACEUTIC ...HEBARD GEORGEInterim PEO and Int ...Option ExerciseA6.1873,500454,23073,500
Nov 08 2012ENZNENZON PHARMACEUTIC ...HEBARD GEORGEInterim PEO and Int ...GrantA0.0024,500043,23718.7 K to 43.2 K (+130.76 %)
Jul 03 2012ENZNENZON PHARMACEUTIC ...SALISBURY ROBERT CDirectorGrantA0.0010,669067,70757 K to 67.7 K (+18.71 %)
Aug 15 2012ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorSellS6.585,82038,30898,115103.9 K to 98.1 K (-5.60 %)
Aug 13 2012ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorSellS6.581,93312,720103,935105.9 K to 103.9 K (-1.83 %)
Jul 03 2012ENZNENZON PHARMACEUTIC ...Young Richard ADirectorGrantA0.0010,669030,23119.6 K to 30.2 K (+54.54 %)
Jul 03 2012ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorGrantA0.0010,6690105,86895.2 K to 105.9 K (+11.21 %)
Jul 03 2012ENZNENZON PHARMACEUTIC ...Deuel ThomasDirectorGrantA0.0010,669032,23121.6 K to 32.2 K (+49.48 %)
Jul 03 2012ENZNENZON PHARMACEUTIC ...Mulligan RichardDirectorGrantA0.0018,670049,06430.4 K to 49.1 K (+61.43 %)
Jul 03 2012ENZNENZON PHARMACEUTIC ...DENNER ALEXANDER JDirectorGrantA0.0021,338060,62039.3 K to 60.6 K (+54.32 %)
Jun 21 2012ENZNENZON PHARMACEUTIC ...HEBARD GEORGEInterim PEO and Int ...BuyP6.885,00034,39518,73713.7 K to 18.7 K (+36.40 %)
Jun 06 2012ENZNENZON PHARMACEUTIC ...Rackear Andrew D.VP and General Coun ...SellS6.811,61410,98356,72058.3 K to 56.7 K (-2.77 %)
Jun 06 2012ENZNENZON PHARMACEUTIC ...Conover CharlesSVP, R&D Program Ma ...SellS6.7825,000169,50057,21382.2 K to 57.2 K (-30.41 %)
Mar 29 2012ENZNENZON PHARMACEUTIC ...Daly TimothyVP, Controller and ...GrantA0.008,00008,0000 to 8 K
Mar 16 2012ENZNENZON PHARMACEUTIC ...Young Richard ADirectorSellS6.922,00013,84219,56221.6 K to 19.6 K (-9.28 %)
Jan 19 2012ENZNENZON PHARMACEUTIC ...Buchbinder AbyVP, Clinical Develo ...Option ExerciseA6.6912,00080,28012,000
Jan 19 2012ENZNENZON PHARMACEUTIC ...Buchbinder AbyVP, Clinical Develo ...GrantA0.004,000058,01554 K to 58 K (+7.41 %)
Feb 29 2012ENZNENZON PHARMACEUTIC ...HEBARD GEORGEDirectorOption ExerciseA7.2810,29774,96210,297
Feb 29 2012ENZNENZON PHARMACEUTIC ...HEBARD GEORGEDirectorGrantA0.0013,737013,7370 to 13.7 K
Jan 19 2012ENZNENZON PHARMACEUTIC ...Conover CharlesSVP, R&D Program Ma ...Option ExerciseA6.6925,000167,25025,000
Jan 19 2012ENZNENZON PHARMACEUTIC ...Conover CharlesSVP, R&D Program Ma ...GrantA0.0010,000082,21372.2 K to 82.2 K (+13.85 %)
Jan 19 2012ENZNENZON PHARMACEUTIC ...Rackear Andrew D.VP and General Coun ...Option ExerciseA6.6925,000167,25025,000
Jan 19 2012ENZNENZON PHARMACEUTIC ...Rackear Andrew D.VP and General Coun ...GrantA0.0010,000058,33448.3 K to 58.3 K (+20.69 %)
Jan 19 2012ENZNENZON PHARMACEUTIC ...Greenberger Lee MVP, ResearchOption ExerciseA6.6912,00080,28012,000
Jan 19 2012ENZNENZON PHARMACEUTIC ...Greenberger Lee MVP, ResearchGrantA0.003,500036,14632.6 K to 36.1 K (+10.72 %)
Jan 19 2012ENZNENZON PHARMACEUTIC ...Stancic AnaExecutive VP, COO, ...GrantA0.0045,000070,00025 K to 70 K (+180.00 %)
Jan 19 2012ENZNENZON PHARMACEUTIC ...Stancic AnaExecutive VP, COO, ...SellD0.0045,000015,00060 K to 15 K (-75.00 %)
Jan 05 2012ENZNENZON PHARMACEUTIC ...Deuel ThomasDirectorOption ExerciseA6.8110,99474,86910,994
Jan 05 2012ENZNENZON PHARMACEUTIC ...Mulligan RichardDirectorOption ExerciseA6.8119,240131,02419,240
Jan 05 2012ENZNENZON PHARMACEUTIC ...SALISBURY ROBERT CDirectorOption ExerciseA6.8110,99474,86910,994
Jan 05 2012ENZNENZON PHARMACEUTIC ...Young Richard ADirectorOption ExerciseA6.8110,99474,86910,994
Jan 05 2012ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorOption ExerciseA6.8110,99474,86910,994
Jan 05 2012ENZNENZON PHARMACEUTIC ...DENNER ALEXANDER JDirectorOption ExerciseA6.8121,988149,73821,988
Dec 20 2011ENZNENZON PHARMACEUTIC ...Daly TimothyVP, Controller and ...Option ExerciseA6.5020,000130,00020,000
Nov 21 2011ENZNENZON PHARMACEUTIC ...Stancic AnaExecutive VP, COO, ...Option ExerciseA6.37125,000796,250155,000
Nov 21 2011ENZNENZON PHARMACEUTIC ...Stancic AnaExecutive VP, COO, ...GrantA0.0045,000070,00025 K to 70 K (+180.00 %)
Nov 10 2011ENZNENZON PHARMACEUTIC ...Rackear Andrew D.VP and General Coun ...SellS6.683,76625,15748,33452.1 K to 48.3 K (-7.23 %)
Nov 10 2011ENZNENZON PHARMACEUTIC ...Buchbinder AbyVP, Clinical Develo ...SellS7.062,70019,06254,01556.7 K to 54 K (-4.76 %)
Sep 19 2011ENZNENZON PHARMACEUTIC ...Greenberger Lee MVP, ResearchPayment of ExerciseF8.335914,92332,64633.2 K to 32.6 K (-1.78 %)
Sep 19 2011ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...Payment of ExerciseF8.338867,380204,633205.5 K to 204.6 K (-0.43 %)
Sep 19 2011ENZNENZON PHARMACEUTIC ...Rackear Andrew D.VP and General Coun ...Payment of ExerciseF8.332,06717,21852,10054.2 K to 52.1 K (-3.82 %)
Sep 19 2011ENZNENZON PHARMACEUTIC ...Buchbinder AbyVP, Clinical Develo ...Payment of ExerciseF8.332,95224,59056,71559.7 K to 56.7 K (-4.95 %)
Aug 16 2011ENZNENZON PHARMACEUTIC ...Buchbinder AbyVP, Clinical Develo ...GrantA0.008,000059,66751.7 K to 59.7 K (+15.48 %)
Aug 16 2011ENZNENZON PHARMACEUTIC ...Rackear Andrew D.VP and General Coun ...GrantA0.0010,000054,16744.2 K to 54.2 K (+22.64 %)
Aug 16 2011ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...GrantA0.0035,0000204,633169.6 K to 204.6 K (+20.63 %)
Jul 06 2011ENZNENZON PHARMACEUTIC ...DENNER ALEXANDER JDirectorGrantA0.0014,764039,28224.5 K to 39.3 K (+60.22 %)
Jul 06 2011ENZNENZON PHARMACEUTIC ...Deuel ThomasDirectorGrantA0.007,382021,56214.2 K to 21.6 K (+52.06 %)
Jul 06 2011ENZNENZON PHARMACEUTIC ...Mulligan RichardDirectorGrantA0.0012,919030,39417.5 K to 30.4 K (+73.93 %)
Jul 06 2011ENZNENZON PHARMACEUTIC ...Young Richard ADirectorGrantA0.007,382021,56214.2 K to 21.6 K (+52.06 %)
Jul 06 2011ENZNENZON PHARMACEUTIC ...SALISBURY ROBERT CDirectorGrantA0.007,382057,03849.7 K to 57 K (+14.87 %)
Jul 06 2011ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorGrantA0.007,382095,19987.8 K to 95.2 K (+8.41 %)
Jul 06 2011ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HRPayment of ExerciseF10.161,96920,005109,314111.3 K to 109.3 K (-1.77 %)
Jun 09 2011ENZNENZON PHARMACEUTIC ...Stancic AnaSenior VP, Finance ...Option ExerciseA10.2230,000306,60030,000
Jun 09 2011ENZNENZON PHARMACEUTIC ...Stancic AnaSenior VP, Finance ...GrantA0.0025,000025,0000 to 25 K
Jun 02 2011ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorSellS10.578,70291,98008.7 K to 0 (-100.00 %)
Apr 05 2011ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...Option ExerciseM0.0016,80000
Apr 05 2011ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...Payment of ExerciseF11.025,95165,580169,633175.6 K to 169.6 K (-3.39 %)
Apr 05 2011ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...BuyM0.0016,8000175,584158.8 K to 175.6 K (+10.58 %)
Apr 05 2011ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOOption ExerciseM0.0016,80000
Apr 05 2011ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOPayment of ExerciseF11.029,380103,368138,476147.9 K to 138.5 K (-6.34 %)
Apr 05 2011ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOBuyM0.0026,4800147,856121.4 K to 147.9 K (+21.82 %)
Apr 05 2011ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HROption ExerciseM0.0012,76000
Apr 05 2011ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HRPayment of ExerciseF11.023,76741,512111,283115.1 K to 111.3 K (-3.27 %)
Apr 05 2011ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HRBuyM0.0012,7600115,050102.3 K to 115.1 K (+12.47 %)
Apr 01 2011ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...Payment of ExerciseF10.768869,533158,784159.7 K to 158.8 K (-0.55 %)
Apr 01 2011ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...BuyJ0.002,5000159,670157.2 K to 159.7 K (+1.59 %)
Apr 01 2011ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOPayment of ExerciseF10.768869,533121,376122.3 K to 121.4 K (-0.72 %)
Apr 01 2011ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOBuyJ0.002,5000122,262119.8 K to 122.3 K (+2.09 %)
Apr 01 2011ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HRPayment of ExerciseF10.763944,239102,290102.7 K to 102.3 K (-0.38 %)
Apr 01 2011ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HRBuyJ0.001,3330102,684101.4 K to 102.7 K (+1.32 %)
Jan 28 2011ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOPayment of ExerciseF11.636,07070,594122,262128.3 K to 122.3 K (-4.73 %)
Jan 28 2011ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOBuyJ0.0016,4650128,332111.9 K to 128.3 K (+14.72 %)
Jan 28 2011ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOPayment of ExerciseF12.156,79382,535128,332135.1 K to 128.3 K (-5.03 %)
Jan 28 2011ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOBuyJ0.0018,3330135,125116.8 K to 135.1 K (+15.70 %)
Mar 01 2011ENZNENZON PHARMACEUTIC ...Ogden Mark LActing VP of Fin & ...BuyP10.652,00021,2984,0002 K to 4 K (+100.00 %)
Feb 24 2011ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorSellS10.8810,000108,81796,519106.5 K to 96.5 K (-9.39 %)
Jan 28 2011ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HRPayment of ExerciseF11.632,53329,459102,684105.2 K to 102.7 K (-2.41 %)
Jan 28 2011ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HRBuyJ0.007,5990105,21797.6 K to 105.2 K (+7.78 %)
Jan 28 2011ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HRPayment of ExerciseF12.151,12413,657105,217106.3 K to 105.2 K (-1.06 %)
Jan 28 2011ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HRBuyJ0.003,3330106,341103 K to 106.3 K (+3.24 %)
Jan 28 2011ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...Payment of ExerciseF11.634,74455,173159,670164.4 K to 159.7 K (-2.89 %)
Jan 28 2011ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...BuyJ0.0012,6650164,414151.7 K to 164.4 K (+8.35 %)
Jan 28 2011ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...Payment of ExerciseF12.156,80282,644164,414171.2 K to 164.4 K (-3.97 %)
Jan 28 2011ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...BuyJ0.0018,3330171,216152.9 K to 171.2 K (+11.99 %)
Jan 05 2011ENZNENZON PHARMACEUTIC ...Deuel ThomasDirectorOption ExerciseA12.4016,996210,75016,996
Jan 05 2011ENZNENZON PHARMACEUTIC ...CLASSON ROLF ADirectorOption ExerciseA12.4016,996210,75016,996
Jan 05 2011ENZNENZON PHARMACEUTIC ...SALISBURY ROBERT CDirectorOption ExerciseA12.4016,996210,75016,996
Jan 05 2011ENZNENZON PHARMACEUTIC ...Young Richard ADirectorOption ExerciseA12.4016,996210,75016,996
Jan 05 2011ENZNENZON PHARMACEUTIC ...Mulligan RichardDirectorOption ExerciseA12.4016,996210,75016,996
Jan 05 2011ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorOption ExerciseA12.4016,996210,75016,996
Jan 05 2011ENZNENZON PHARMACEUTIC ...DENNER ALEXANDER JDirectorOption ExerciseA12.4033,991421,48833,991
Nov 24 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOOption ExerciseM0.003,00000
Nov 24 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOPayment of ExerciseF10.921,06311,608137,125138.2 K to 137.1 K (-0.77 %)
Nov 24 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOBuyM0.003,0000138,188135.2 K to 138.2 K (+2.22 %)
Nov 24 2010ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...Option ExerciseM0.004,00000
Nov 24 2010ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...Payment of ExerciseF10.921,41715,474180,216181.6 K to 180.2 K (-0.78 %)
Nov 24 2010ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Princ. Exec ...BuyM0.004,0000181,633177.6 K to 181.6 K (+2.25 %)
Nov 24 2010ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HROption ExerciseM0.004,00000
Nov 24 2010ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HRPayment of ExerciseF10.921,18112,897105,556106.7 K to 105.6 K (-1.11 %)
Nov 24 2010ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HRBuyM0.004,0000106,737102.7 K to 106.7 K (+3.89 %)
Sep 24 2010ENZNENZON PHARMACEUTIC ...del Campo RalphCOO and Principal E ...GrantA0.0015,0000177,633162.6 K to 177.6 K (+9.22 %)
Sep 24 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, President of R ...GrantA0.0015,0000135,188120.2 K to 135.2 K (+12.48 %)
Sep 24 2010ENZNENZON PHARMACEUTIC ...Davit Paul StephenExec. Vice Pres. HRGrantA0.008,0000102,73794.7 K to 102.7 K (+8.44 %)
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOOption ExerciseM7.4079,200586,08066,500
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOOption ExerciseM7.14162,8001,162,3920
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOOption ExerciseM7.142,00014,280162,800
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOOption ExerciseM7.1435,200251,328164,800
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOOption ExerciseM6.9735,000243,9500
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOSellS10.63200,0002,126,660120,188320.2 K to 120.2 K (-62.46 %)
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOBuyM7.4079,200586,080320,188241 K to 320.2 K (+32.86 %)
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOBuyM7.14162,8001,162,392240,98878.2 K to 241 K (+208.22 %)
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOSellS10.671,70018,13278,18879.9 K to 78.2 K (-2.13 %)
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOBuyM7.142,00014,28079,88877.9 K to 79.9 K (+2.57 %)
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOSellS10.8157,200618,20077,888135.1 K to 77.9 K (-42.34 %)
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOBuyM7.1435,200251,328135,08899.9 K to 135.1 K (+35.24 %)
Sep 17 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOBuyM6.9735,000243,95099,88864.9 K to 99.9 K (+53.94 %)
Sep 07 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOOption ExerciseM0.0020,00000
Sep 07 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOPayment of ExerciseF10.587,08474,94964,88872 K to 64.9 K (-9.84 %)
Sep 07 2010ENZNENZON PHARMACEUTIC ...HORAK IVAN DEVP, R&D, CSOBuyM0.0020,000071,97252 K to 72 K (+38.48 %)
Aug 27 2010ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorSellS10.495,00052,425106,519111.5 K to 106.5 K (-4.48 %)
Aug 27 2010ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorSellS10.514004,204111,519111.9 K to 111.5 K (-0.36 %)
Aug 27 2010ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorSellS10.504,60048,300111,919116.5 K to 111.9 K (-3.95 %)
Jul 06 2010ENZNENZON PHARMACEUTIC ...DENNER ALEXANDER JDirectorGrantA0.0014,086024,51810.4 K to 24.5 K (+135.03 %)
Jul 06 2010ENZNENZON PHARMACEUTIC ...Mulligan RichardDirectorGrantA0.007,043017,47510.4 K to 17.5 K (+67.51 %)
Jul 06 2010ENZNENZON PHARMACEUTIC ...Deuel ThomasDirectorGrantA0.007,043014,1807.1 K to 14.2 K (+98.68 %)
Jul 06 2010ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorOption ExerciseM0.003,17300
Jul 06 2010ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorBuyM0.003,1730116,519113.3 K to 116.5 K (+2.80 %)
Jul 06 2010ENZNENZON PHARMACEUTIC ...LEBUHN ROBERTDirectorGrantA0.007,0430113,346106.3 K to 113.3 K (+6.63 %)
Jul 06 2010ENZNENZON PHARMACEUTIC ...CLASSON ROLF ADirectorOption ExerciseM0.003,17300
Jul 06 2010ENZNENZON PHARMACEUTIC ...CLASSON ROLF ADirectorBuyM0.003,173055,32052.1 K to 55.3 K (+6.08 %)
Jul 06 2010ENZNENZON PHARMACEUTIC ...CLASSON ROLF ADirectorGrantA0.007,043052,14745.1 K to 52.1 K (+15.62 %)
Jul 06 2010ENZNENZON PHARMACEUTIC ...Young Richard ADirectorGrantA0.007,043014,1807.1 K to 14.2 K (+98.68 %)
Jul 06 2010ENZNENZON PHARMACEUTIC ...SALISBURY ROBERT CDirectorOption ExerciseM0.003,17300
Jul 06 2010ENZNENZON PHARMACEUTIC ...SALISBURY ROBERT CDirectorBuyM0.003,173049,65646.5 K to 49.7 K (+6.83 %)
Jul 06 2010ENZNENZON PHARMACEUTIC ...SALISBURY ROBERT CDirectorGrantA0.007,043046,48339.4 K to 46.5 K (+17.86 %)
Jul 06 2010ENZNENZON PHARMACEUTIC ...MICATI VICTOR PDirectorOption ExerciseM0.003,17300
Jul 06 2010ENZNENZON PHARMACEUTIC ...MICATI VICTOR PDirectorBuyM0.003,173050,62547.5 K to 50.6 K (+6.69 %)

Page:   1 2 3 4 5 ... 5 next >